ARTICLE | Finance

Eyes in Europe

Why Bristol-Myers Squibb invested in LSP's latest European life sciences fund

December 7, 2015 8:00 AM UTC

Bristol-Myers Squibb Co. (NYSE:BMY) is banking on LSP's expertise in early stage European investing to give the pharma access to emerging technologies and companies on the Continent.

For its first-ever investment in a European healthcare fund, the pharma put an undisclosed amount into LSP 5. While LSP was not actively looking for new strategic investors, Joachim Rothe told BioCentury the firm is happy to play a role as BMS's European scout...